Xiong Li
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 18, 2025
A Hybrid compound H93 treats prostate cancer by directly binding UHRF1 and promoting protein dimerization.Yuxin Fu, Longying Jiang, Guojian Xie
|Nov 24, 2024
SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability.Yuchong Peng, Xuli Qi, Liuyang Ding
|Oct 03, 2023
PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability.Yuchong Peng, Youhong Liu, Rirong Zheng
|Sep 20, 2023
UHRF1 promotes spindle assembly and chromosome congression by catalyzing EG5 polyubiquitination.Xuli Qi, Youhong Liu, Yuchong Peng
|Aug 10, 2023
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer.Linglong Yin, Yubing Ye, Ling Zou
|Jan 02, 2023
AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer.Yongming Fu, Tuoyu Cao, Xiaorui Zou
Pageof 1
